SGEM#370 - By admin - July 02, 2022
Reference: McGinnis et al. Major adverse cardiac event rates in moderate-risk patients: Does prior coronary disease matter? AEM June 2022.
…”Many patients risk stratified as “non-low” risk are admitted, but the benefit of objective cardiac testing in this cohort is unclear in the absence of elevated troponins or abnormal EKGs [6-9]. The study we will be reviewing today seeks asks if the presence of known coronary artery disease is predictive of major adverse cardiac events (MACE) in a previously identified non-low risk group of patients…”
SGEM BOTTOM LINE: IT MAY BE REASONABLE, IN PATIENTS WHO ARE MODERATE RISK BY THE HEART SCORE BUT DO NOT HAVE EXISTING KNOWN CAD, TO PURSUE OUTPATIENT FOLLOW UP INSTEAD OF URGENT INPATIENT WORKUP.